Location History:
- New York City, NY (US) (2017)
- New York, NY (US) (2017 - 2020)
Company Filing History:
Years Active: 2017-2020
Title: Innovations in Cardiac Ablation: The Contributions of Vivek Y Reddy
Introduction
Vivek Y Reddy is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of cardiac ablation. With a total of 3 patents to his name, Reddy has made strides in developing methods and systems that enhance the safety and efficacy of cardiac procedures.
Latest Patents
One of Reddy's latest patents focuses on a method and systems for occluding vessels during cardiac ablation, which includes optional electroanatomical guidance. This innovative method involves inserting an occlusion catheter into a vessel on the heart, occluding the vessel, and then inserting an ablation catheter into a chamber of the heart. The ablation catheter is positioned against the myocardium, allowing for the ablation of a portion of the myocardium while the vessel remains occluded. The system features an occlusion catheter with a tubular member, a balloon designed to contact the inner surface of the coronary sinus, and a series of marker bands and electrodes positioned on the catheter body. This design allows for enhanced precision during cardiac procedures.
Career Highlights
Reddy's work is primarily associated with St. Jude Medical, Atrial Fibrillation Division, Inc., where he has played a crucial role in advancing cardiac treatment technologies. His innovative approaches have contributed to improved patient outcomes in the management of atrial fibrillation and other cardiac conditions.
Collaborations
Reddy has collaborated with notable colleagues in the field, including James V Kauphusman and Andre d'Avila. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge technologies in cardiac care.
Conclusion
Vivek Y Reddy's contributions to cardiac ablation technology exemplify the impact of innovation in the medical field. His patents and collaborative efforts continue to shape the future of cardiac treatment, ultimately benefiting patients worldwide.